Chongqing Xishan Science&Technology688576.SHValuation Analysis

As of Oct 19, 2026, Chongqing Xishan Science&Technology (688576.SH) trades at a negative P/E (-311.82x, due to a recent net loss), P/B of 1.48x, P/S of 10.30x, and a dividend yield of 0.91%.
Longitudinal percentile comparison: P/E historical percentile is still accumulating data over the trailing long-term window (vs. the short-term percentile still accumulating data); P/B sits at the 7th percentile over the trailing 10Y window (vs. 8th percentile over 3Y); P/S sits at the 33rd percentile over the trailing 10Y window (vs. 37th percentile over 3Y).
Cross-sectional valuation: its P/B ranks at the 19th percentile within its industry and the 21st percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 2.81%, ranking at the 72nd percentile over the trailing 20Y window.
Its P/B percentile is roughly the same whether measured against the industry or the broader market. Of the 2.81% total shareholder yield, 0.91% is paid out as dividends and roughly 1.90% is implied to come from buybacks — both channels are meaningfully in play. Chongqing Xishan Science&Technology operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.